These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1075 related items for PubMed ID: 14500659

  • 1. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis.
    Zhang Z, Jimi E, Bothwell AL.
    J Immunol; 2003 Oct 01; 171(7):3620-6. PubMed ID: 14500659
    [Abstract] [Full Text] [Related]

  • 2. Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways.
    Zhang YH, Heulsmann A, Tondravi MM, Mukherjee A, Abu-Amer Y.
    J Biol Chem; 2001 Jan 05; 276(1):563-8. PubMed ID: 11032840
    [Abstract] [Full Text] [Related]

  • 3. Activin A stimulates IkappaB-alpha/NFkappaB and RANK expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors.
    Sugatani T, Alvarez UM, Hruska KA.
    J Cell Biochem; 2003 Sep 01; 90(1):59-67. PubMed ID: 12938156
    [Abstract] [Full Text] [Related]

  • 4. Lipopolysaccharide-induced osteoclastogenesis in Src homology 2-domain phosphatase-1-deficient viable motheaten mice.
    Hayashi S, Tsuneto M, Yamada T, Nose M, Yoshino M, Shultz LD, Yamazaki H.
    Endocrinology; 2004 Jun 01; 145(6):2721-9. PubMed ID: 14988381
    [Abstract] [Full Text] [Related]

  • 5. Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6.
    Mizukami J, Takaesu G, Akatsuka H, Sakurai H, Ninomiya-Tsuji J, Matsumoto K, Sakurai N.
    Mol Cell Biol; 2002 Feb 01; 22(4):992-1000. PubMed ID: 11809792
    [Abstract] [Full Text] [Related]

  • 6. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma.
    Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K, Taniguchi T.
    Nature; 2000 Nov 30; 408(6812):600-5. PubMed ID: 11117749
    [Abstract] [Full Text] [Related]

  • 7. Osteoclast differentiation by RANKL requires NF-kappaB-mediated downregulation of cyclin-dependent kinase 6 (Cdk6).
    Ogasawara T, Katagiri M, Yamamoto A, Hoshi K, Takato T, Nakamura K, Tanaka S, Okayama H, Kawaguchi H.
    J Bone Miner Res; 2004 Jul 30; 19(7):1128-36. PubMed ID: 15176996
    [Abstract] [Full Text] [Related]

  • 8. Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis.
    Bharti AC, Takada Y, Aggarwal BB.
    J Immunol; 2004 May 15; 172(10):5940-7. PubMed ID: 15128775
    [Abstract] [Full Text] [Related]

  • 9. The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: increased resorption and osteopenia in me(v)/me(v) mutant mice.
    Aoki K, Didomenico E, Sims NA, Mukhopadhyay K, Neff L, Houghton A, Amling M, Levy JB, Horne WC, Baron R.
    Bone; 1999 Sep 15; 25(3):261-7. PubMed ID: 10495129
    [Abstract] [Full Text] [Related]

  • 10. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts.
    Lee ZH, Kim HH.
    Biochem Biophys Res Commun; 2003 May 30; 305(2):211-4. PubMed ID: 12745060
    [Abstract] [Full Text] [Related]

  • 11. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X, Li Z, Yang Z, Zheng C, Jing J, Chen Y, Ye X, Lian X, Qiu W, Yang F, Tang J, Xiao J, Liu M, Luo J.
    J Bone Miner Res; 2012 Jun 30; 27(6):1298-1308. PubMed ID: 22337253
    [Abstract] [Full Text] [Related]

  • 12. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro].
    Xiao XH, Zhou HD, Yuan LQ, Xie H, Liao EY.
    Zhonghua Yi Xue Za Zhi; 2004 Dec 17; 84(24):2102-6. PubMed ID: 15730627
    [Abstract] [Full Text] [Related]

  • 13. The possible role of TGF-beta-induced suppressors of cytokine signaling expression in osteoclast/macrophage lineage commitment in vitro.
    Fox SW, Haque SJ, Lovibond AC, Chambers TJ.
    J Immunol; 2003 Apr 01; 170(7):3679-87. PubMed ID: 12646633
    [Abstract] [Full Text] [Related]

  • 14. IL-3 acts directly on osteoclast precursors and irreversibly inhibits receptor activator of NF-kappa B ligand-induced osteoclast differentiation by diverting the cells to macrophage lineage.
    Khapli SM, Mangashetti LS, Yogesha SD, Wani MR.
    J Immunol; 2003 Jul 01; 171(1):142-51. PubMed ID: 12816992
    [Abstract] [Full Text] [Related]

  • 15. Distinct domains in the SHP-2 phosphatase differentially regulate epidermal growth factor receptor/NF-kappaB activation through Gab1 in glioblastoma cells.
    Kapoor GS, Zhan Y, Johnson GR, O'Rourke DM.
    Mol Cell Biol; 2004 Jan 01; 24(2):823-36. PubMed ID: 14701753
    [Abstract] [Full Text] [Related]

  • 16. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P, Tu Q, Chen J.
    J Bone Miner Res; 2005 Sep 01; 20(9):1669-79. PubMed ID: 16059638
    [Abstract] [Full Text] [Related]

  • 17. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
    Xing L, Bushnell TP, Carlson L, Tai Z, Tondravi M, Siebenlist U, Young F, Boyce BF.
    J Bone Miner Res; 2002 Jul 01; 17(7):1200-10. PubMed ID: 12096833
    [Abstract] [Full Text] [Related]

  • 18. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
    Mizuno K, Tagawa Y, Mitomo K, Arimura Y, Hatano N, Katagiri T, Ogimoto M, Yakura H.
    J Immunol; 2000 Aug 01; 165(3):1344-51. PubMed ID: 10903736
    [Abstract] [Full Text] [Related]

  • 19. Mutation of the hematopoietic cell phosphatase (Hcph) gene is associated with resistance to gamma-irradiation-induced apoptosis in Src homology protein tyrosine phosphatase (SHP)-1-deficient "motheaten" mutant mice.
    Hsu HC, Shultz LD, Su X, Shi J, Yang PA, Relyea MJ, Zhang HG, Mountz JD.
    J Immunol; 2001 Jan 15; 166(2):772-80. PubMed ID: 11145649
    [Abstract] [Full Text] [Related]

  • 20. Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling.
    Rahman MM, Bhattacharya A, Fernandes G.
    J Lipid Res; 2006 Aug 15; 47(8):1739-48. PubMed ID: 16702601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.